Clinical Trial

Study of DISC-0974-201 in Participants With IBD and Anemia

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This is a Phase 2, multicenter, randomized, double-blind placebo-controlled study of DISC-0974 to evaluate safety, tolerability, and efficacy in participants with IBD and anemia of inflammation.
Protocol Amendment History 10 amendments
This ClinicalTrials.gov record has been amended 10 times since 2026-01-23; most recent amendment 2026-07-09.
Status change: Not Yet Recruiting → Recruiting 2026-02-24
Trial Details
NCT Number NCT07368972
Lead Sponsor Disc Medicine, Inc
Conditions Inflammatory Bowel Disease (IBD), Anemia, Inflammatory Bowel Disease (IBD); Anemia
Enrollment 21 participants
Start Date 2026-02-20
Primary Completion 2026-10 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-08-03